These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11790989)

  • 1. Giant cell arteritis.
    Levine SM; Hellmann DB
    Curr Opin Rheumatol; 2002 Jan; 14(1):3-10. PubMed ID: 11790989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Review Article.
    Nwadibia U; Larson E; Fanciullo J
    S D Med; 2016 Mar; 69(3):121-3. PubMed ID: 27156261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of giant cell arteritis.
    Cantini F; Niccoli L; Nannini C; Bertoni M; Salvarani C
    Drugs Aging; 2008; 25(4):281-97. PubMed ID: 18361539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of giant cell arteritis.
    González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
    Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity.
    Berti A; Campochiaro C; Cavalli G; Pepe G; Praderio L; Sabbadini MG; Dagna L
    Autoimmun Rev; 2015 Apr; 14(4):352-7. PubMed ID: 25528219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA; Bijlsma JW; Derksen RH
    Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early large vessel systemic vasculitis in adults.
    González-Gay MA; Prieto-Peña D; Martínez-Rodríguez I; Calderon-Goercke M; Banzo I; Blanco R; Castañeda S
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101424. PubMed ID: 31810548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing vasculitis with ultrasound: findings and pitfalls.
    Schmidt WA; Schäfer VS
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241251742. PubMed ID: 38846756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and Treatment Approaches.
    Ciofalo A; Gulotta G; Iannella G; Pasquariello B; Manno A; Angeletti D; Pace A; Greco A; Altissimi G; de Vincentiis M; Magliulo G
    Curr Rheumatol Rev; 2019; 15(4):259-268. PubMed ID: 30827250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
    Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
    Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell arteritis: a multicenter observational study in Brazil.
    Souza AW; Okamoto KY; Abrantes F; Schau B; Bacchiega AB; Shinjo SK
    Clinics (Sao Paulo); 2013; 68(3):317-22. PubMed ID: 23644850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.
    Dejaco C; Duftner C; Buttgereit F; Matteson EL; Dasgupta B
    Rheumatology (Oxford); 2017 Apr; 56(4):506-515. PubMed ID: 27481272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
    Schmidt WA
    Dtsch Med Wochenschr; 2020 Jul; 145(13):895-902. PubMed ID: 32615604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
    Salvarani C; Gabriel SE; Gertz MA; Bjornsson J; Li CY; Hunder GG
    Arthritis Rheum; 1994 Nov; 37(11):1621-6. PubMed ID: 7980674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Giant cell arteritis--old questions, current answers].
    Bnaya A; Nesher G; Sonenblick M; Breuer GS
    Harefuah; 2014 Dec; 153(12):747-50, 751. PubMed ID: 25654918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
    Tuckwell K; Collinson N; Dimonaco S; Klearman M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Unizony SH; Stone JH;
    Semin Arthritis Rheum; 2017 Apr; 46(5):657-664. PubMed ID: 27998620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.